Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Gastrointestinal Stromal Tumors
June 1, 2018
SU11248 Effective in Gastrointestinal Stromal Tumors (GIST)
Dr. C H Weaver MD
May 25, 2018
Protein Mutations May Predict Outcomes for GIST Patients Treated with Gleevec®
Dr. C H Weaver MD
October 7, 2014
Gastrointestinal Carcinoid Tumor: Lanreotide Is a Convenient, Effective Drug
Dr. C H Weaver MD
March 9, 2010
Should Oncologists Give Cancer Patients A Survival Timeline?
Dr. C H Weaver MD
March 8, 2009
Regorafenib May Expand GIST Treatment Options
Dr. C H Weaver MD
March 8, 2009
Sutent® Approved for GIST
Dr. C H Weaver MD
March 8, 2009
Two-gene Test Correctly Distinguishes GIST from Leiomyosarcoma
Dr. C H Weaver MD
March 8, 2009
Postoperative Enteral Nutrition Reduces Complications in Gastrointestinal Cancer
Dr. C H Weaver MD
June 21, 2007
Sutent® Improves Outcomes for Patients with GIST
Dr. C H Weaver MD
Previous Page
1
2
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
